Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study)

被引：1

作者：

Lucocq, James ^{[1
]}

Joseph, Nejo ^{[2
]}

Hawkyard, Jake ^{[2
]}

Haugk, Beate ^{[2
]}

White, Steve ^{[2
]}

Lye, Jonathan ^{[2
]}

Parkinson, Daniel ^{[2
]}

Mownah, Omar ^{[3
]}

Menon, Krishna ^{[3
]}

Furukawa, Takaki ^{[4
]}

Hirose, Yuki ^{[4
]}

Sasahira, Naoki ^{[4
]}

Inoue, Yosuke ^{[4
]}

Mittal, Anubhav ^{[5
]}

Samra, Jas ^{[5
]}

Sheen, Amy ^{[6
]}

Feretis, Michael ^{[7
]}

Balakrishnan, Anita ^{[7
]}

Ceresa, Carlo ^{[8
]}

Davidson, Brian ^{[8
]}

Pande, Rupaly ^{[9
]}

Dasari, Bobby ^{[9
]}

Roberts, Keith ^{[9
]}

Tanno, Lulu ^{[10
]}

Karavias, Dimitrios ^{[10
]}

Helliwell, Jack ^{[11
]}

Young, Alistair ^{[11
]}

Marks, Kate ^{[11
]}

Nunes, Quentin ^{[12
]}

Urbonas, Tomas ^{[13
]}

Silva, Michael ^{[13
]}

Gordon-Weeks, Alex ^{[13
]}

Barrie, Jenifer ^{[14
]}

Gomez, Dhanny ^{[14
]}

van Laarhoven, Stijn ^{[15
]}

Nawara, Hossam ^{[15
]}

Doyle, Joseph ^{[16
]}

Bhogal, Ricky ^{[16
]}

Harrison, Ewen ^{[17
]}

Roalso, Marcus ^{[18
]}

Ciprani, Debora ^{[19
]}

Aroori, Somaiah ^{[19
]}

Ratnayake, Bathiya ^{[20
]}

Koea, Jonathan ^{[20
]}

Capurso, Gabriele ^{[21
,22
]}

Stattner, Stefan ^{[23
]}

Bellotti, Ruben ^{[24
]}

Alsaoudi, Tareq ^{[24
]}

Bhardwaj, Neil ^{[24
]}

Rajesh, Srujan ^{[24
]}

机构：

[1] NHS Lothian, Dept Gen Surg, Aberdeen, Scotland

[2] Freeman Rd Hosp, Hepatopancreatobiliary & Transplant Unit, Newcastle Upon Tyne, England

[3] Kings Coll Hosp London, Dept Hepatobiliary & Pancreat Surg, Denmark Hill, London, England

[4] Canc Inst Hosp Japanese Fdn Canc Res, Hepatobiliary Pancreat Med Dept, Tokyo, Japan

[5] Royal North Shore Hosp, Sydney, NSW, Australia

[6] Royal North Shore Hosp, Dept Anat Pathol, New South Wales Hlth Pathol, Sydney, NSW, Australia

[7] Addenbrookes Hosp, Cambridge Hepatobiliary & Pancreat Surg Unit, Cambridge, England

[8] Royal Free Hosp, Hepatobiliary & Pancreat Surg Unit, London, England

[9] Queen Elizabeth Hosp Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Hepatobiliary & Pancreat Surg Unit, Birmingham, England

[10] Univ Hosp Southampton, Hepatobiliary & Pancreat Surg Unit, Acad Surg Unit, Southampton, England

[11] Leeds Teaching Hosp NHS Fdn Trust, Hepatobiliary & Pancreat Surg Unit, Leeds, England

[12] East Lancashire Teaching Hosp NHS Trust, Dept Hepatobiliary Surg, Blackburn, Lancs, England

[13] Oxford Univ Hosp NHS Fdn Trust, Oxford Hepatopancreatobiliary HPB Surg Unit, Oxford, England

[14] Nottingham Univ Hosp NHS Fdn Trust, Nottingham Hepatopancreaticoniliary HPB Serv, Nottingham, England

[15] Univ Hosp Bristol & Weston NHS Fdn trust, Dept Hepatobiliary & Pancreat Surg, Bristol, England

[16] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England

[17] Univ Edinburgh, Dept Clin Surg, Edinburgh, Scotland

[18] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway

[19] Univ Hosp Plymouth NHS Trust, Hepatopancreatobiliary Unit, Plymouth, England

[20] North Shore Hosp, Hepatopancreaticobiliary Upper Gastrointestinal Un, Auckland, New Zealand

[21] S Andrea Hosp, Digest & Dis Unit, Rome, Italy

[22] Univ Vita Salute San Raffaele, San Raffaele Sci Inst IRCCS, Pancreas Ctr, Milan, Italy

[23] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria

[24] Univ Hosp Leicester NHS Trust, Leicester Hepatopancreatobiliary Unit, Leicester, England

[25] Christchurch Hosp, Dept Gen & Vasc Surg, Canterbury Dist Hlth Board, Canterbury, New Zealand

[26] Univ Glasgow, Res Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Scotland

[27] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia

来源：

SURGERY | 2024年 / 176卷 / 03期

关键词：

PANCREATIC-CANCER; ADJUVANT THERAPY; MANAGEMENT; DISTINCT; IMPACT;

D O I：

10.1016/j.surg.2024.05.010

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasms are unknown. This study determines predictors of long-term (>5 years) disease-free survival and recurrence in adenocarcinoma arising from intraductal papillary mucinous neoplasms and derives a prognostic model for disease-free survival. Methods: Consecutive patients who underwent pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasms in 18 academic pancreatic centers in Europe and Asia between 2010 to 2017 with at least 5-year follow-up were identified. Factors associated with disease-free survival were determined using Cox proportional hazards model. Internal validation was performed, and discrimination and calibration indices were assessed. Results: In the study, 288 patients (median age, 70 years; 52% male) were identified; 140 (48%) patients developed recurrence after a median follow-up of 98 months (interquartile range, 78.4-123), 57 patients (19.8%) developed locoregional recurrence, and 109 patients (37.8%) systemic recurrence. At 5 years after resection, the overall and disease-free survival was 46.5% (134/288) and 35.0% (101/288), respectively. On Cox proportional hazards model analysis, multivisceral resection (hazard ratio, 2.20; 95% confidence interval, 1.06-4.60), pancreatic tail location (hazard ratio, 2.34; 95% confidence interval, 1.22-4.50), poor tumor differentiation (hazard ratio, 2.48; 95% confidence interval, 1.10-5.30), lymphovascular invasion (hazard ratio, 1.74; 95% confidence interval, 1.06-2.88), and perineural invasion (hazard ratio, 1.83; 95% confidence interval, 1.09-3.10) were negatively associated with long-term disease-free survival. The final predictive model incorporated 8 predictors and demonstrated good predictive ability for disease-free survival (C-index, 0.74; calibration, slope 1.00). Conclusion: A third of patients achieve long-term disease-free survival (>5 years) after pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasms. The predictive model developed in the current study can be used to estimate the probability of long-term disease-free survival. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

引用

页码：890 / 898

页数：9

共 28 条

[11]

Hamilton S., 2000, Pathology and genetics of tumours of the digestive system

[12] IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy [J].

Kaiser, Joerg ;

Scheifele, Cornelius ;

Hinz, Ulf ;

Leonhardt, Carl-Stephan ;

Hank, Thomas ;

Koenig, Anna-Katharina ;

Tjaden, Christine ;

Hackert, Thilo ;

Bergmann, Frank ;

Buechler, Markus W. ;

Strobel, Oliver .

EJSO, 2022, 48 (06) :1309-1320

[13] MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages [J].

Kato, Hiroyuki ;

Tateishi, Keisuke ;

Fujiwara, Hiroaki ;

Nakatsuka, Takuma ;

Yamamoto, Keisuke ;

Kudo, Yotaro ;

Hayakawa, Yoku ;

Nakagawa, Hayato ;

Tanaka, Yasuo ;

Ijichi, Hideaki ;

Otsuka, Motoyuki ;

Iwadate, Dosuke ;

Oyama, Hiroki ;

Kanai, Sachiko ;

Noguchi, Kensaku ;

Suzuki, Tatsunori ;

Sato, Tatsuya ;

Hakuta, Ryunosuke ;

Ishigaki, Kazunaga ;

Saito, Kei ;

Saito, Tomotaka ;

Takahara, Naminatsu ;

Kishikawa, Takahiro ;

Hamada, Tsuyoshi ;

Takahashi, Ryota ;

Miyabayashi, Koji ;

Mizuno, Suguru ;

Kogure, Hirofumi ;

Nakai, Yousuke ;

Hirata, Yoshihiro ;

Toyoda, Atsushi ;

Ichikawa, Kazuki ;

Qu, Wei ;

Morishita, Shinichi ;

Arita, Junichi ;

Tanaka, Mariko ;

Ushiku, Tetsuo ;

Hasegawa, Kiyoshi ;

Fujishiro, Mitsuhiro ;

Koike, Kazuhiko .

GASTROENTEROLOGY, 2022, 162 (04) :1272-+

[14] Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma [J].

Katz, Matthew H. G. ;

Wang, Huamin ;

Fleming, Jason B. ;

Sun, Charlotte C. ;

Hwang, Rosa F. ;

Wolff, Robert A. ;

Varadhachary, Gauri ;

Abbruzzese, James L. ;

Crane, Christopher H. ;

Krishnan, Sunil ;

Vauthey, Jean-Nicolas ;

Abdalla, Eddie K. ;

Lee, Jeffrey E. ;

Pisters, Peter W. T. ;

Evans, Douglas B. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) :836-847

[15] Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study) [J].

Lucocq, James ;

Hawkyard, Jake ;

Robertson, Francis P. ;

Haugk, Beate ;

Lye, Jonathan ;

Parkinson, Daniel ;

White, Steve ;

Mownah, Omar ;

Zen, Yoh ;

Menon, Krishna ;

Furukawa, Takaaki ;

Inoue, Yosuke ;

Hirose, Yuki ;

Sasahira, Naoki ;

Feretis, Michael ;

Balakrishnan, Anita ;

Zelga, Piotr ;

Ceresa, Carlo ;

Davidson, Brian ;

Pande, Rupaly ;

Dasari, Bobby ;

Tanno, Lulu ;

Karavias, Dimitrios ;

Helliwell, Jack ;

Young, Alistair ;

Nunes, Quentin ;

Urbonas, Tomas ;

Silva, Michael ;

Gordon-Weeks, Alex ;

Barrie, Jenifer ;

Gomez, Dhanny ;

van Laarhoven, Stijn ;

Doyle, Joseph ;

Bhogal, Ricky ;

Harrison, Ewen ;

Roalso, Marcus ;

Ciprani, Debora ;

Aroori, Somaiah ;

Ratnayake, Bathiya ;

Koea, Jonathan ;

Capurso, Gabriele ;

Bellotti, Ruben ;

Staettner, Stefan ;

Alsaoudi, Tareq ;

Bhardwaj, Neil ;

Jeffery, Fraser ;

Connor, Saxon ;

Cameron, Andrew ;

Jamieson, Nigel ;

Sheen, Amy .

ANNALS OF SURGERY, 2024, 280 (01) :126-135

[16] Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights [J].

Mas, Leo ;

Lupinacci, Renato M. ;

Cros, Jerome ;

Bachet, Jean-Baptiste ;

Coulet, Florence ;

Svrcek, Magali .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)

[17] The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN) [J].

McMillan, Matthew T. ;

Lewis, Russell S. ;

Drebin, Jeffrey A. ;

Teitelbaum, Ursina R. ;

Lee, Major K. ;

Roses, Robert E. ;

Fraker, Douglas L. ;

Vollmer, Charles M. .

CANCER, 2016, 122 (04) :521-533

[18] The 2019 WHO classification of tumours of the digestive system [J].

Nagtegaal, Iris D. ;

Odze, Robert D. ;

Klimstra, David ;

Paradis, Valerie ;

Rugge, Massimo ;

Schirmacher, Peter ;

Washington, Kay M. ;

Carneiro, Fatima ;

Cree, Ian A. .

HISTOPATHOLOGY, 2020, 76 (02) :182-188

[19] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial [J].

Neoptolemos, John P. ;

Palmer, Daniel H. ;

Ghaneh, Paula ;

Psarelli, Eftychia E. ;

Valle, Juan W. ;

Halloran, Christopher M. ;

Faluyi, Olusola ;

O'Reilly, Derek A. ;

Cunningham, David ;

Wadsley, Jonathan ;

Darby, Suzanne ;

Meyer, Tim ;

Gillmore, Roopinder ;

Anthoney, Alan ;

Lind, Pehr ;

Glimelius, Bengt ;

Falk, Stephen ;

Izbicki, Jakob R. ;

Middleton, Gary William ;

Cummins, Sebastian ;

Ross, Paul J. ;

Wasan, Harpreet ;

McDonald, Alec ;

Crosby, Tom ;

Ma, Yuk Ting ;

Patel, Kinnari ;

Sherriff, David ;

Soomal, Rubin ;

Borg, David ;

Sothi, Sharmila ;

Hammel, Pascal ;

Hackert, Thilo ;

Jackson, Richard ;

Buechler, Markus W. .

LANCET, 2017, 389 (10073) :1011-1024

[20] Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas [J].

Rodrigues, Clifton ;

Hank, Thomas ;

Qadan, Motaz ;

Ciprani, Debora ;

Mino-Kenudson, Mari ;

Weekes, Colin D. ;

Ryan, David P. ;

Clark, Jeffrey W. ;

Allen, Jill N. ;

Hong, Theodore S. ;

Wo, Jennifer Y. ;

Ferrone, Cristina R. ;

Warshaw, Andrew L. ;

Lillemoe, Keith D. ;

Fernandez-del Castillo, Carlos .

PANCREATOLOGY, 2020, 20 (04) :722-728

← 1 2 3 →